The purpose of this study is to compare clinical outcomes in the treatment of deep non-contained intrabony defects ( i.e. , with 70 % 1-wall component and a residual 2 - to 3-wall component in the most apical part ) using deproteinized bovine bone mineral ( DBBM ) combined with either enamel matrix protein derivative ( EMD ) or collagen membrane ( CM ) .